tsn

RUSH University Medical Center Team Identifies Prenol as Robust Inhibitor of SARS-CoV-2 Spike Protein

 734
2 comments
Staff at TrialSite | Quality Journalism
Jul. 8, 2023, 6:00 p.m.

A team of biomedical researchers represented by Rush University, Chicago biochemist Kalipada Pahan, Ph.D., report on a series of laboratory experiments suggesting fruit consumption might just help fight viral infections such as SARS-CoV-2, the virus behind COVID-19. Is vitamin C the answer? Not so fast. Enter prenol, a natural alcohol with potential.

The role of this important or as the authors in the study report titled “Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19” deem a “celebrity” component of the fruit as to its role unclear.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News